ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,883, issued on Nov. 25, was assigned to Genentech Inc. (South San Francisco, Calif.) and Hoffmann-La Roche Inc. (Little Falls, N.J.).
"Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform" was invented by Michael Leiss (Schlehdorf, Germany), Christian Meyer (Starnberg, Germany), Alexandra Thomas Morris (Pacifica, Calif.), Bernhard Spensberger (Eberfing, Germany), Yinges Yigzaw (San Ramon, Calif.), Franziska Edelmann (Wolfratshausen, Germany), Roberto Falkenstein (Munich), Tobias Graf (Penzberg, Germany), Jie Gu (Thousand Oaks, Calif.) and Jeevan Prabhakar (San Francisco).
According to the abstract* released by the U.S. ...